By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

European Commission (EC) 

Rue Joseph II
Jozef II straat 70
Brussels    B-1000  Belgium
Phone: n/a Fax: n/a


SEARCH JOBS


Industry
Medical Device






Company News
European Commission (EC) Approves Ipsen (IPN.PA)’s Cabometyx (Cabozantinib) Tablets For The Treatment Of Advanced Renal Cell Carcinoma (RCC) In Adults Following Prior Vascular Endothelial Growth Factor (VEGF)-Targeted Therapy 9/14/2016 10:22:59 AM
MeMed Diagnostics Release: €2.3 Million Award By European Commission (EC) Will Support Deployment Of Immunoxpert To Reduce Antibiotic Misuse In Hospitals 9/8/2016 11:27:14 AM
European Commission (EC) Approves Bristol-Myers Squibb (BMY)’s ORENCIA (Abatacept) For The Treatment Of Highly Active And Progressive Disease In Adult Patients With Rheumatoid Arthritis Not Previously Treated With Methotrexate 9/6/2016 11:40:36 AM
Alexion (ALXN) Release: European Commission (EC) Grants Orphan Drug Designation To ALXN1007 For The Treatment Of Patients With Graft-Versus-Host Disease (GVHD) 8/30/2016 11:41:00 AM
European Commission (EC) Grants Marketing Authorization For Gilead (GILD)’s Once-Daily Truvada® For Reducing The Risk Of Sexually Acquired HIV-1 8/22/2016 11:00:33 AM
European Commission (EC) Grants Marketing Authorization For Teva (TEVA)’s CINQAERO (Reslizumab) 8/18/2016 9:35:36 AM
Merck & Co. (MRK)’s KEYTRUDA (Pembrolizumab) Approved By The European Commission (EC) For Patients With Advanced Non-Small Cell Lung Cancer (NSCLC) Whose Tumors Express PD-L1 8/3/2016 9:43:46 AM
European Commission (EC) Grants Marketing Authorization For Merck & Co. (MRK)’s ZEPATIER (Elbasvir/Grazoprevir) For The Treatment Of Chronic Hepatitis C Infection 7/29/2016 9:04:07 AM
Celgene (CELG) Release: REVLIMID (Lenalidomide) Approved By The European Commission (EC) For The Treatment Of Relapsed/Refractory Patients With Mantle Cell Lymphoma 7/15/2016 11:22:39 AM
European Commission (EC) Grants Marketing Authorization For Gilead (GILD)’s Epclusa (Sofosbuvir/Velpatasvir) For The Treatment Of All Genotypes Of Chronic Hepatitis C 7/8/2016 10:40:51 AM
12345678910...
//-->